MTOR and breast cancer: In line to a possible involvement of mTOR in the inhibition of C. parvum infection, an oleocanthal-driven reduction in mTOR phosphorylation by more than 50% was demonstrated in MDA-MB-231 breast cancer cells treated for 72 h with 10 μM oleocanthal [31].